Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management https://t.co/5KvitAoUey
@CartlandDavid Treating physicians in charge of patients with post-vaccination lymphadenopathy should consider the possibility of an underlying or coincidental malignant disorder. https://t.co/YPVOyEP2V9
@indepdubnrth Regional lymphadenopathy has been rarely reported following administration of vaccinations for TB, influenza & HP. In 2021 there seems to have been an increase in cases with clinically enlarged axillary/supraclavicular nodes or lymphade
Jab-related lymphadenopathy (normally a hallmark of cancer) lasts over 100 days https://t.co/EDy0r6il3L
How to manage raised lymph nodes after COVID vaccination - Clinical practice information for the growing number of patients who will present with vaccine-related unilateral axillary and/or supraclavicular lymphadenopathy (palpable or image detected). https